Rapid reporting and review of an increased incidence of a known adverse event

J Natl Cancer Inst. 2000 Jun 21;92(12):1011-3. doi: 10.1093/jnci/92.12.1011.
No abstract available

Publication types

  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Adverse Drug Reaction Reporting Systems / organization & administration*
  • Adverse Drug Reaction Reporting Systems / standards
  • Antineoplastic Agents / adverse effects*
  • Clinical Trials as Topic / standards*
  • Clinical Trials, Phase I as Topic / standards
  • Clinical Trials, Phase II as Topic / standards
  • Clinical Trials, Phase III as Topic / standards
  • Diarrhea / chemically induced
  • Drugs, Investigational / adverse effects
  • Humans
  • Incidence
  • Multicenter Studies as Topic / standards*
  • National Institutes of Health (U.S.)
  • Neutropenia / chemically induced
  • United States
  • United States Food and Drug Administration
  • Vomiting / chemically induced

Substances

  • Antineoplastic Agents
  • Drugs, Investigational